Cost-effectiveness of Pembrolizumab for Previously Treated MSI-H/dMMR Solid Tumours in the UK.

Grant Mccarthy,Kate Young,Matthew Madin-Warburton, Tyler Mantaian, Elizabeth Brook,Kaylie Metcalfe,Jan Mikelson,Ruifeng Xu, Carl Seyla-Hammer,Raquel Aguiar-Ibanez,Mayur Amonkar

JOURNAL OF MEDICAL ECONOMICS（2024）

引用 0|浏览12

暂无评分

关键词

Microsatellite instability,mismatch repair deficient,economic analysis,cost-effectiveness,pembrolizumab,multi-tumour,histology-independent,D61,D6,H51,H5

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要